2.2. Study Participants
METASTASES
Patients enrolled within the ongoing RADIOSA trial and with a minimum follow-up of six months were considered for study inclusion. All patients were stratified into two treatment arms according to the administration of ADT and the location of the metastases. This trial had been approved by the Ethics Committee of the IEO and Centro Cardiologico Monzino (IEO UID 997). All patients signed a dedicated informed consent before trial enrollment.